Monoclonal Antibody Therapy in Rheumatoid Arthritis
- 1 August 1996
- journal article
- review article
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 6 (2) , 143-153
- https://doi.org/10.1007/bf03259511
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1994
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritisArthritis & Rheumatism, 1993
- MONOCLONAL ANTIBODY TREATMENT IN RHEUMATOID ARTHRITIS: THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF A CD7 MONOCLONAL ANTIBODYRheumatology, 1991
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndromeArthritis & Rheumatism, 1989
- MONOCLONAL ANTI-CD4 IN ARTHRITISThe Lancet, 1987
- Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid jointClinical Immunology and Immunopathology, 1987